ALERT: Your health is top priority. We’re committed to providing reliable COVID-19 resources to keep you informed and safe.

FDA Change Would Weaken Already Weak Reporting System, Critics Say


Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Food and Drug Administation (FDA) approval process in the U.S.

The U.S. Food and Drug Administration is supposed to protect consumers from dangerous medical devices. But that agency is considering a new proposal that could endanger the public by making less information available about problems with devices.

The proposed change would allow makers of eligible devices to report malfunctions quarterly and in a summary format. Currently, manufacturers are given 30 days after a device malfunctions to submit to the FDA a detailed report on that specific device.

The agency says the change is needed because it would save its employees from having to conduct duplicate reviews of common malfunctions. This, the agency maintains, will lead to more efficiency.

Consumer advocates and patients strongly oppose the change. They say loosening the requirements for device manufacturers will limit the amount of information available to the public about device malfunctions.

“I am opposed to this change because it weakens an already weak adverse event reporting system, which will endanger patients and hamper clinician’s access to important adverse event data,” said Rita Redberg, an expert who has authored several studies critical of the FDA’s medical device regulation and clinical trials.

Public commenting on the proposal ended Monday. The FDA did not say which devices would be eligible for the change.

Consumer advocates urged the agency to release the product codes of eligible devices and extend comments to allow them to better evaluate the impact of the change.
“Without this list it is impossible for members of the public to fully understand the safety implications of the proposed program,” said Michael A. Carome, director of Public Citizen’s Health Research Group.

The FDA is not wrong to take a look at its medical device reporting system. But the proposed change could be a move in the wrong direction. The public needs more information from medical device makers, not less.

Elaine Silvestrini
Written By Elaine Silvestrini Writer

Elaine Silvestrini is an award-winning journalist with 30 years of experience covering state and federal court systems. She joined Drugwatch in 2017. Her coverage for Drugwatch has been cited in the CDC’s Public Health Law News and the USA Today Network. Some of her qualifications include:

  • Centers for Disease Control and Prevention certificates in Health Literacy
  • Experience as an assistant investigator for the Federal Public Defender
  • Loyola Law School Journalist Law School Fellowship
Edited By
Emily Miller
Emily Miller Managing Editor

2 Cited Research Articles writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.

  1. U.S. Food and Drug Administration. (2017, December 22). FDA In Brief: FDA proposes new program for reporting medical device malfunctions to increase efficiency and more effectively detect potential safety issues. Retrieved
  2. Federal Register. (n.d.). Center for Devices and Radiological Health; Medical Devices and Combination Products; Voluntary Malfunction Summary Reporting Program for Manufacturers. Retrieved
View All Sources
Who Am I Calling?

Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.

Drugwatch's sponsors support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our sponsors page.

(888) 645-1617